Adverse event systems
This article was originally published in The Tan Sheet
Executive Summary
HHS program to consolidate patient safety data reporting and collecting efforts beginning with systems housed at FDA, CDC unveiled Nov. 25. Agency for Healthcare Research & Quality's two-year, $5.9 mil. contract with KEVRIC Co. (Silver Spring, Md.) will lead to development of a Web-based system to link FDA's drugs, medical devices, biologics, vaccines adverse event systems that receive reports from doctors, nurses, healthcare providers with CDC's National Healthcare Safety Network. Following initial two-year period, second phase of the project could extend to adverse event reporting for foods, FDA says...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.